help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frieden, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frieden, T. R.
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 359, (2006)
© 2006 American Thoracic Society


Correspondence

Lack of Directly Observed Treatment Affects Tuberculosis Relapse Rates

To the Editor:

The findings of Seyler and colleagues as reported in their recent article regarding risk factors for tuberculosis relapse among patients receiving antiretroviral treatment for HIV infection are potentially important (1). However, self-administration of antituberculosis drugs in the Ivory Coast likely affected reported tuberculosis relapse rates.

Patients who self-administer antituberculosis treatment are much more likely to relapse than patients who receive directly observed therapy (2, 3). In addition, self-administration of antituberculosis treatment increases the likelihood of inconsistent treatment; patients whose treatment is irregular or interrupted are 2.5 times more likely to relapse than adherent patients (4).

Directly observed antituberculosis treatment reduces the risk of relapse and death (5). Whether post-treatment prophylaxis would be indicated among patients who received optimal directly observed therapy for tuberculosis is not yet known.

Thomas R. Frieden

Commissioner, New York City Department of Health and Mental Hygiene, New York, New York

FOOTNOTES

Conflict of Interest Statement: T.R.F. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med 2005;172:123–127.[Abstract/Free Full Text]
  2. Balasubramanian VN, Oommen K, Samuel R. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis 2000;4:409–413.[Medline]
  3. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330: 1179–1184.[Abstract/Free Full Text]
  4. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, Eusuff SI, Sadacharam K, Narayanan PR. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005;9:556–561.[Medline]
  5. Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS 1994;8:1103–1108.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frieden, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frieden, T. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society